Forecasts data is unavailable for this security.
Consensus recommendation
- 20-Feb-25
- 20-Nov-25
- 18-Dec-25
- 15-Jan-26
- 05-Feb-26
Select bar for recommendation details.
| Recommendations | 05-Feb-26 | |
|---|---|---|
| Buy | 4 | |
| Outperform | 4 | |
| Hold | 2 | |
| Sell | 0 | |
| Strong Sell | 0 |
Share price forecast in USD
The 8 analysts offering 12 month price targets for Cabaletta Bio Inc have a median target of 14.00, with a high estimate of 30.00 and a low estimate of 2.00. The median estimate represents a 457.77% increase from the last price of 2.51.
| High | 1,095.2% | 30.00 |
| Med | 457.8% | 14.00 |
| Low | -20.3% | 2.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Mar 30, 2026.
| Average growth rate | +5.71% |
| Average growth rate | -14.63% |
More ▼
Revenue history & estimates in USD
| Average growth rate | 0.00% |
| Average growth rate | 0.00% |
More ▼
